OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of oncolytic virotherapy: from genetic modification to combination therapy
Qiaoshuai Lan, Shuai Xia, Qian Wang, et al.
Frontiers of Medicine (2020) Vol. 14, Iss. 2, pp. 160-184
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Oncolytic virotherapy: basic principles, recent advances and future directions
Danni Lin, Yinan Shen, Tingbo Liang
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 165

Extracellular Vesicles and Viruses: Two Intertwined Entities
Coline Moulin, Mathieu J. F. Crupi, Carolina S. Ilkow, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1036-1036
Open Access | Times Cited: 50

Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
Lalitha Palanivelu, Ching-Hsuan Liu, Liang Lin
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 37

Oncolytic virotherapy in cancer treatment: challenges and optimization prospects
Lingjuan Chen, Mengsi Zuo, Qin Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35

Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective
Palaniyandi Muthukutty, So Young Yoo
Viruses (2023) Vol. 15, Iss. 8, pp. 1645-1645
Open Access | Times Cited: 26

Recent Advances in pH and Redox Responsive Polymer Nanocomposites for Cancer Therapy
Shivalingayya Gaddimath, Shivanand Payamalle, Keshavananada Prabhu Channabasavana Hundi Puttaningaiah, et al.
Journal of Composites Science (2024) Vol. 8, Iss. 1, pp. 28-28
Open Access | Times Cited: 15

Recent advances in mesenchymal stem cell therapy for multiple sclerosis: clinical applications and challenges
Kamran Sheikhi, Sara Ghaderi, Hassan Firouzi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access | Times Cited: 1

Mechanistic Modeling of the Elution Behavior and Convective Entrapment of Vesicular Stomatitis Virus on an Ion Exchange Chromatography Monolith
Adrian Schimek, Judy King Man Ng, Fritz G. Will, et al.
Journal of Chromatography A (2025) Vol. 1748, pp. 465832-465832
Closed Access | Times Cited: 1

Nucleic Acid-Based Approaches for Tumor Therapy
Simone Hager, Frederic Julien Fittler, Ernst Wagner, et al.
Cells (2020) Vol. 9, Iss. 9, pp. 2061-2061
Open Access | Times Cited: 56

Materials promoting viral gene delivery
Kübra Kaygisiz, Christopher V. Synatschke
Biomaterials Science (2020) Vol. 8, Iss. 22, pp. 6113-6156
Open Access | Times Cited: 51

Development of oncolytic viruses for cancer therapy
Noraini Abd-Aziz, Chit Laa Poh
Translational research (2021) Vol. 237, pp. 98-123
Closed Access | Times Cited: 50

Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option
Yi Ren, Jia-Meng Miao, Yuan-yuan Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33

Current Trends in Cancer Immunotherapy
Ivan Y. Filin, Valeriya V. Solovyeva, Kristina V. Kitaeva, et al.
Biomedicines (2020) Vol. 8, Iss. 12, pp. 621-621
Open Access | Times Cited: 43

Mechanisms of Cancer Resistance to Various Therapies
Asiya Batool, Waseem Rashid, Kaneez Fatima, et al.
(2024), pp. 31-75
Closed Access | Times Cited: 5

Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements
Ketao Jin, Wenlin Du, Yu‐Yao Liu, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 588-588
Open Access | Times Cited: 29

Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying IL-24/endostatin enhances glioma therapy
Junhe Zhang, Hao Chen, Chen Chen, et al.
Cancer Letters (2021) Vol. 509, pp. 26-38
Closed Access | Times Cited: 28

Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy
Zhongbing Qi, Xiangyu Long, Jiyan Liu, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 19

Combination of Oncolytic Virotherapy with Different Antitumor Approaches against Glioblastoma
Alisa B. Ageenko, Natalia S. Vasileva, Vladimir A. Richter, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2042-2042
Open Access | Times Cited: 4

Engineered virus-mimicking nanovaccine with lymph node–tumor dual-targeting and STING-activating capacity for robust cancer immunotherapy
Zhongjie Wang, Shu‐Jun Liu, Ruiqi Ming, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 416-427
Closed Access | Times Cited: 4

Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical
Chao Tang, Lan Li, Tong Mo, et al.
Clinical & Translational Oncology (2022) Vol. 24, Iss. 9, pp. 1682-1701
Open Access | Times Cited: 17

Immunogenic cell death-based oncolytic virus therapy: a sharp sword of tumor immunotherapy
Jingyu Zhang, Jiahe Chen, Kezhi Lin
European Journal of Pharmacology (2024) Vol. 981, pp. 176913-176913
Open Access | Times Cited: 3

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
Volker Schirrmacher, Stefaan Van Gool, Wilfried Stuecker
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13050-13050
Open Access | Times Cited: 16

OV Modulators of the Paediatric Brain TIME: Current Status, Combination Strategies, Limitations and Future Directions
Konstantinos Vazaios, Ronja E. van Berkum, Friso Calkoen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5007-5007
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top